AGILON HEALTH INC
AGLNYSE🏆 #1599 by market capUS Equity
$86.88▼ $9.29 (−10.69%)
Live1h—
24h▼ 10.7%
7d▼ 8.3%
14d▼ 12.0%
30d▼ 24.6%
1y▲ 304.7%
🏦Market Cap
$1.45B
Small Cap
📈Revenue Growth (YoY)
+0.3%
Slowing
📊Gross Margin
3.8%
Thin
💵FCF Margin
—
⚖️P/S Ratio
0.3x
Cheap
Otter Score
64
Fair
Trading Snapshot
- Day Range
- $85.55 – $88.50
- 52-Week Range
- $7.48 – $133.04
- Volume
- $6.65B
- Avg Volume
- $6.20B
- Shares Outstanding
- 16.7M
- Next Earnings
- Sep 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $5.92B
- Last Q Revenue
- $1.58B
- P/E Ratio
- —
- P/S Ratio
- 0.3x
- EPS (TTM)
- $-14.06
- Dividend Yield
- —
Why Investors Own AGL
- ✓High-growth profile — revenue up +25.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 67% gross margin and 25% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$5.92B▲ +29.8% YoY
Gross Margin (TTM)
67.3%▲ +3.1% YoY
Operating Income (TTM)
$1.68B▲ +29.8% YoY
Free Cash Flow (TTM)
$1.49B▲ +29.8% YoY
About AGILON HEALTH INC
A company profile for AGILON HEALTH INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
64/100
Analyst Price Target
ⓘAverage Target
$110.78
▲ +27.5% Upside
High Target$132.78
Low Target$93.62
Based on 14 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
AGILON HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift AGL price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
AGILON HEALTH INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.